Status:
RECRUITING
An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.
Lead Sponsor:
Hercules
Collaborating Sponsors:
Prenuvo Inc
Conditions:
Cancer
Metabolic Disease
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, single-arm, observational study capturing data from whole-body magnetic resonance imagining (WB-MRI) from up to 100,000 male and female subjects 18 years of age or older recruit...
Eligibility Criteria
Inclusion
- Each subject MUST:
- Be\>=18 years of age at the time of enrollment.
- Be able to read and understand provided procedural information for the study;
- Be able and willing to follow all study procedures including proper breathing and body movement minimization while within the WB-MRI system;
- Be willing and able to provide required clinical, demographic, medical history, and concomitant medications information;
- Be able to provide financial payment in advance for reimbursement of the cost of the WBMRI acquisition procedure and interpretation;
- Complete all required consent procedures.
Exclusion
- Harbor within their bodies contraindicated medical devices including, but not limited to, implanted pacemakers, intracranial aneurysm clips, cochlear implants, drug infusion pumps, neurostimulators, bone growth stimulators, certain intrauterine contraceptive devices, non- MRI safe metals, etc.;
- Self-certify that they are pregnant;
- Be seeking to undergo WB-MRI as a subject in this study in lieu of other covered dedicated diagnostic imaging evaluations when such covered procedures represent more appropriate or standard-of-care procedures by context-specific clinical indication;
- Be an employee of the study site or the sponsor;
- Have a medical condition or serious intercurrent illness, or other circumstance that, in the Investigator's judgment, could jeopardize the candidate's safety as a study subject, or that could interfere with study objectives.
Key Trial Info
Start Date :
May 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2037
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT06212479
Start Date
May 17 2024
End Date
January 1 2037
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hercules Research Center
Watertown, Massachusetts, United States, 02472